Endocannabinoid System Clinical Research: Cannabis DKJ127 Trial
The Cannabis DK127 clinical trial demonstrated significant pain reduction in chronic low back pain patients using the full-spectrum cannabis extract VER-01. This phase 3 study showed sustained benefits over 12 weeks compared to placebo. The trial…
Evaluating Safety in Cannabinoid Clinical Trials for Mental Health
Cannabinoid clinical trials mental health safety data reveal limited evidence supporting cannabinoids as primary treatments for mental disorders. Current trials show inconclusive efficacy and safety profiles. Patients should prioritize evidence-based…
How Cannabinoid Signaling Shapes Insulin Sensitivity in Humans
Cannabinoid receptor insulin sensitivity is explored in a controlled human trial using gold-standard metabolic clamp techniques. The findings show that CB1 receptor activity can shift insulin sensitivity without altering insulin secretion. This study…
Justice Department Plans Could Ease Medical Marijuana Restrictions, Allowing Rochester Lab
Cannabis research regulatory changes are under consideration by the Justice Department to ease restrictions on medical marijuana studies. These changes could enable Rochester labs to expand investigations into cannabis pharmacology. This shift may…
Trump’s Cannabis Reclassification: What It Means for Research and Medicine
Cannabis reclassification research under Schedule III could remove federal barriers limiting clinical studies. This shift may accelerate evidence generation on cannabis’s therapeutic effects and safety. Clinicians should monitor developments carefully as…
Teen Pot Use Continues to Decline Post-Legalization | Cannabis Sciences – Labroots
Declining adolescent cannabis use post-legalization challenges prior predictions of increased youth access. This trend suggests that regulation and age restrictions may be effective public health measures. Clinicians should monitor these changes to…
Trump Administration Moves Medical Use of Marijuana to Less Strict Category – WBLS
The medical marijuana rescheduling by the Trump administration reduces regulatory barriers, enabling more clinical research. This shift allows for better evidence on cannabis efficacy and safety. Clinicians can expect improved guidance for patient care…
DOJ reschedules medical marijuana, leaves out NY’s recreational shops
When federal policy moves at glacial speed, state retail operations are left asking whether they’re legal, illegal, or trapped in regulatory purgatory. Turns out “complicated” is not a scheduling category. Via r/trees Further Reading…
Do you use weed to enhance amorous times? If so, what’s your fav way to share the experience with your partner/s?
When THC lowers inhibitions and increases blood flow, the pharmacology becomes as important as the chemistry between partners. Just remember, consent and communication are the only compounds that should never be diluted. Via r/trees Further Reading…
Impact of Maternal Cannabis Exposure on Child Neurodevelopment
Maternal cannabis exposure and risk of ASD ADHD in offspring is a critical area of research. Studies show associations between peripregnancy cannabis use and behavioral outcomes in children. These findings highlight the importance of understanding…